Testosterone CV Safety, From Signal To Label

 
• By Bridget Silverman

The Pink Sheet Drug Review Profile breaks down the FDA's long reckoning with testosterone cardiovascular safety concerns

Postmarket safety evaluation of a product is rarely simple and direct. (Shutterstock)

More from Drug Review Profiles

More from Product Reviews